Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 23andMe Holding Co. ME

Consumer Cyclical Healthcare Advertising Agencies
23andMe Holding Co. is a genetics-led consumer healthcare and biopharmaceutical company. The Company operates through two segments: Consumer & Research Services and Therapeutics. The Consumer & Research Services business segment comprises its Personal Genome Service (PGS), telehealth business, and research service. PGS services provide customers with a broad suite of genetic reports, including... see more

Recent & Breaking News (NDAQ:ME)

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador's Precision Medicines for Immunology & Inflammation

GlobeNewswire 1 day ago

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

GlobeNewswire 9 days ago

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

GlobeNewswire 10 days ago

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

GlobeNewswire 13 days ago

23andMe to Report Q2 FY2025 Financial Results

GlobeNewswire November 7, 2024

23andMe Regains Compliance With Nasdaq Listing Requirements

GlobeNewswire October 30, 2024

23andMe Appoints Three New Independent Directors to Board

GlobeNewswire October 29, 2024

23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South

GlobeNewswire October 17, 2024

23andMe Announces Completion of 1-for-20 Reverse Stock Split

GlobeNewswire October 16, 2024

23andMe Announces 1-for-20 Reverse Stock Split

GlobeNewswire October 11, 2024

23andMe Announces Mathew Knowles as New Brand Ambassador

GlobeNewswire October 8, 2024

ME INVESTOR ALERT: An Investigation into the Board of 23andMe Holding Co. has been Initiated - Current Shareholders are Encouraged to Contact BFA Law

Accesswire September 30, 2024

ME INVESTOR ALERT: 23andMe Holding Co. Shareholders are Urged to Contact BFA Law about Investigation into the Company

Newsfile September 30, 2024

ME INVESTOR NEWS: Current 23andMe Holding Co. Investors are Notified of Continuing Investigation into the Company's Board of Directors and Urged to Contact BFA Law

Newsfile September 28, 2024

ME INVESTIGATION UPDATE: 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law about the Potential Lawsuit against the Company

Accesswire September 27, 2024

ME INVESTIGATION ALERT BFA Law Notifies 23andMe Holding Co. Current Shareholders to Contact the Firm about its Investigation into the Board of Directors

Newsfile September 26, 2024

ME INVESTOR UPDATE: BFA Law Alerts 23andMe Holding Co. Shareholders to Contact the Firm about its Investigation into the Company's Board of Directors (Nasdaq:ME)

Accesswire September 26, 2024

ME INVESTOR NEWS: If You are a Current Shareholder of 23andMe Holding Co., Contact BFA Law about its Investigation into the Board of Directors

Newsfile September 25, 2024

23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating

GlobeNewswire September 25, 2024

ME SHAREHOLDER NEWS: Current 23andMe Holding Co. Shareholders are Encouraged to Contact BFA Law about Investigation into the Company for Breaches of Fiduciary Duties

Accesswire September 24, 2024